HomeAI · summaries
Storia in 3 fonti
Pharmalittle: We're reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more
Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvals
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions
Gamblers can now bet on how experimental drugs will perform in clinical trials—and if they’ll get FDA approval.
- ·
statnews.com
Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.
